Late-Onset Neonatal Sepsis
15
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (15)
NICU Antibiotics and Outcomes Trial
Evaluation of bioMarkErs to Reduce Antibiotics Use in hospitalizeD nEonates
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants
The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.
The Effect of Probiotics Added to the Mother's Diet on Preterm Babies
Clinical Impact of Donor Milk Pasteurized by HTST Treatment in Preterm Infants
Topical Coconut Oil Application and Incidence of Sepsis in Neonates
Effect of Kangaroo Care on Heart Rate Variability in Late-onset Neonatal Sepsis
Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.
Characterization of Intestinal Microbiota Stability in Preterm Born Neonates
Bovine Colostrum for Preterm Newborns
Bovine Colostrum as a Human Milk Fortifier for Preterm Infants
Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)
Effectiveness of Oral Immunotherapy Among Preterm Babies